OTC · Financial Statements
BioAdaptives Inc. (BDPT) Financial Statements
$0.00
OTC: BDPT
Market Cap $28461
Overview Financials Dividend
BioAdaptives Inc. most recently reported annual revenue of $0, net profit of $-2.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $0 $0 $0 $0 $0 Operating Profit $-1.0M $0 $0 $-1.0M $-1.0M Net Profit $-1.0M $-1.0M $-1.0M $-1.0M $-2.0M EPS $-4.67 $-1.27 $-0.12 $-0.11 $-0.15 Op Margin -3216.0% -2456.9% -801.7% -4751.8% -5701.8%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $0 $0 $0 $0 $0 Total Liabilities $1.0M $1.0M $2.0M $2.0M $2.0M Cash $0 $0 $0 $0 $0 Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $0 $0 $0 $0 $-1.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $0 $0 $0 $0 $0 Free Cash Flow $0 $0 $0 $0 $-1.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.33 FCF Yield -1830.43% Quick Ratio 0.04 Interest Coverage -6.64 Return 1Y -89.55% Return 3Y -98.98% Return 5Y -99.96%
Screens featuring this stock